VICENTE GARRIGUES GIL, M.D.; JOAQUIN BERENGUER LAPUERTA, M.D.; JULIO PONCE GARCIA, M.D.; MIGUEL RAYON MARTIN, M.D.
To the editor: We report a case of intrahepatic cholestasis that occurred in a pregnant woman after she received a nonalkylated anabolic steroid.
A 27-year-old woman (para 3, gravida 14 weeks) was admitted to our unit because of jaundice. Her family and personal histories were uneventful. Five-and-a-half months earlier, she had developed fatigue, nausea, and upper abdominal pain. Treatment with metoclopramide hydrochloride was given for a few days, and 50 mg of cyclohexylpropionate of 19-norandrostenolone was administered intramuscularly every 15 days. Four months later she complained of jaundice, mild pruritus, light stools, and dark urine without fever or chills. She
GIL VG, LAPUERTA JB, GARCIA JP, MARTIN MR. A Non-C17-Alkylated Steroid and Long-term Cholestasis. Ann Intern Med. 1986;104:135–136. doi: 10.7326/0003-4819-104-1-135_2
Download citation file:
Published: Ann Intern Med. 1986;104(1):135-136.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use